Evidence map›Paper›PMID 40276171›Full record

ArticleOpen veterinary journal2025

Impacts of

Mohammed Fadhil K Alrubaie, Sura Safi Khafaji

Abstract read
In one paragraph

Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. The protective effects of the combination ofOpen veterinary journal · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohammed Fadhil K AlrubaieDepartment of Physiology, Biochemistry and Pharmacology, College of Veterinary Medicine, Al-Qassim Green University, Ministry of Higher Education and Scientific Research, Al-Qassim City, Iraq.
Sura Safi KhafajiDepartment of Physiology, Biochemistry and Pharmacology, College of Veterinary Medicine, Al-Qassim Green University, Ministry of Higher Education and Scientific Research, Al-Qassim City, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A mancozeb, belonging to a pesticide, can induce testicular injury via free radical generation and antioxidant suppression. Aim: This study aimed to compare and evaluate the therapeutic roles of Methods: Testicular toxicity was induced by oral administration of mancozeb (MCZ) at a dose of 313.6 mg/Kg for 4 weeks. Fifty male rats were allocated randomly into 5 groups, each group contained 10 rats. The first group (control group; C), second group (mancozeb group; MCZ) was orally administered 313.6 mg/Kg of mancozeb as a single dose/day for 4 weeks, third group (MCZ+PPE) received MCZ as the second group then administered Results: Testicular follicle-stimulating hormone receptor (FSHr) and luteinizing hormone receptor (LHr) gene expression was significantly upregulated in rats that received PPE + LC+ MCZ compared with the experimental rats. The seminal fluid quality was significantly elevated while abnormal morphology significantly declined in the MCZ+PPE, MCZ+LC, and MCZ+PPE+LC groups compared with the MCZ group. The serum FSH, testosterone, LH, and antioxidant enzymes, superoxide dismutase, and glutathione peroxidase, increased significantly, whereas malondialdehyde decreased significantly in rats that received PPE+ LC+ MCZ compared with all experimental rats. In addition, based on testicular-histopathological investigations, the administration of both PPE and LC, alone or in combination, can improve testicular disarrangement due to mancozeb-induced testicular damage. Conclusion: The administration of

Indexed as

CarnitineFlavonoidsGene ExpressionManebPinusPlant ExtractsTestisZinebAnimalsAntioxidantsFungicides, IndustrialMaleRatsRats, WistarAntioxidantsCarnitineFlavonoidsFungicides, IndustrialmancozebManebPlant ExtractspycnogenolsZinebL. carnitineMancozebPinus pinasterTesticular atrophyTherapeutic

Identifiers

PMID40276171
PMCPMC12017718

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.